요역동학 장비 시장 : 유형별, 용도별, 최종 사용자별, 지역별(2025-2033년)

The global urodynamic equipment market size reached USD 373.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 565.8 Million by 2033, exhibiting a growth rate (CAGR) of 4.49% during 2025-2033. The increasing prevalence of urological disorders, the rising geriatric population, and the introduction of wireless urodynamic equipment represent some of the key factors driving the market.

Urodynamic equipment refers to a specialized medical device used to evaluate the functioning of the urinary system. It is comprised of several components, such as a catheterization kit, pressure transducer, filling pump, flow meter, and computerized data acquisition system. It is designed to measure various parameters of the bladder and the urethra, such as pressure, volume, and flow rate. Urodynamic equipment is widely used to treat urinary incontinence, voiding dysfunction, neurogenic bladder, interstitial cystitis, and prostate problems. It provides detailed, accurate, and measured information about urinary functions, which aids healthcare professionals in early disease diagnosis, making informed decisions, and selecting appropriate treatment options. Urodynamic equipment also enhances patients' comfort, improves clinical outcomes, reduces healthcare expenditure, and minimizes the risk of complications.

Urodynamic Equipment Market Trends:

The increasing prevalence of urological disorders due to urinary tract infections (UTIs), enlarged prostates, medications, and unhealthy lifestyles is one of the primary factors providing a thrust to the market growth. Urodynamic equipment is widely used to assess urinary function, identify abnormalities, and measure bladder capacity, pressure, and flow rate to diagnose various diseases and identify underlying causes. In addition to this, the widespread equipment utilization to evaluate the effectiveness of different urinary treatments, such as surgery, medications, and pelvic exercises, is acting as another growth-inducing factor. Furthermore, the rising geriatric population with high susceptibility to urological diseases, owing to hormonal changes, weak urinary tract muscles, and chronic conditions, such as diabetes, hypertension, and cardiovascular diseases (CVDs), is providing an impetus to the market growth. Apart from this, the increasing awareness among the masses regarding early diagnosis of urinary disorders to prevent future complications, such as cancer, kidney damage, and sexual dysfunction, is propelling the market growth. Additionally, the introduction of wireless urodynamic equipment, which is portable, compact, lightweight, provides remote monitoring capabilities, and eliminates the need for patients to visit healthcare facilities regularly, is positively influencing the market growth. Besides this, the utilization of artificial intelligence (AI) to improve the accuracy of diagnoses and aid healthcare professionals in developing personalized treatment plans is favoring the market growth. Moreover, the implementation of supportive government policies to incentivize patients and provides access to high-quality treatment options are contributing to the market growth. Other factors, including rapid expansion of the healthcare industry, extensive research and development (R&D) activities, and the growing demand for minimally invasive (MI) procedures, are anticipated to drive the market growth.

Key Market Segmentation:

Type Insights:

• Uroflowmetry Equipment
• Cystometry
• Ambulatory Urodynamic Systems
• Electromyographs
• Video Urodynamic Systems
• Urodynamic Consumables

Application Insights:

• Kidney Diseases
• Cancer
• Others

End User Insights:

• Hospitals
• Ambulatory Centers
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for urodynamic equipment. Some of the factors driving the North America urodynamic equipment market included the rising prevalence of urological disorders, the implementation of various government initiatives, and rapid technological advancements.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global urodynamic equipment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Delta Med S.p.A., Gemini Medical Technologies, Laborie Inc., Medica SpA, Medkonsult medical technology s.r.o., Neomedix Systems Pty. Ltd., Schippers Medizintechnik, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global urodynamic equipment market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global urodynamic equipment market?
• What is the impact of each driver, restraint, and opportunity on the global urodynamic equipment market?
• What are the key regional markets?
• Which countries represent the most attractive urodynamic equipment market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the urodynamic equipment market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the urodynamic equipment market?
• What is the breakup of the market based on end user?
• Which is the most attractive end user in the urodynamic equipment market?
• What is the competitive structure of the global urodynamic equipment market?
• Who are the key players/companies in the global urodynamic equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Urodynamic Equipment Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Uroflowmetry Equipment
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Cystometry
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Ambulatory Urodynamic Systems
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Electromyographs
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Video Urodynamic Systems
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Urodynamic Consumables
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Application

• 7.1 Kidney Diseases
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cancer
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Delta Med S.p.A.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Gemini Medical Technologies
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Laborie Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Medica SpA
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Medkonsult medical technology s.r.o.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Neomedix Systems Pty. Ltd.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Schippers Medizintechnik
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.